Top Industry Leaders in the Tetanus Toxoid Vaccine Market
Latest Tetanus toxoid vaccine Companies Updates:
Jan 2024
Serum Institute of India Expanded their production capacity for tetanus toxoid vaccine to meet the needs of global immunization programs, particularly in low- and middle-income countries.Collaborated with Gavi, the Vaccine Alliance, to provide affordable tetanus vaccines for children and pregnant women in developing countries.
Sanofi Pasteur Received FDA approval for their next-generation tetanus toxoid vaccine with improved stability and shelf life, enabling its use in challenging environments.Introduced a combination vaccine containing tetanus toxoid, diphtheria toxoid, and acellular pertussis antigen for simplified childhood immunization schedules.
Bharat Biotech International Ltd Developed a novel nasal spray vaccine containing tetanus toxoid for potential needle-free and painless immunization, particularly beneficial for children and needle-phobic individuals.Partnered with academic institutions to conduct clinical trials on the nasal spray vaccine's efficacy and safety.
Merck & Co.,Launched an educational campaign highlighting the importance of tetanus booster vaccinations for adults and pregnant women.Collaborated with healthcare providers to improve tetanus vaccination rates and awareness of its life-saving benefits.
World Health Organization (WHO) Established a new global goal to eliminate tetanus as a public health threat by 2030.Launched initiatives to strengthen surveillance systems, improve vaccine delivery infrastructure, and combat vaccine hesitancy.
List of Tetanus toxoid vaccine Key companies in the market:
- GlaxoSmithKline Plc.
- Merck & Co. Inc.
- Pfizer, Inc.
- Sanofi Pasteur, Inc.
- AstraZeneca Plc.
- Bharat Biotech
- Shenzhen Kangtai Biological Products
- Valeant Pharmaceuticals
- Emergent Biosolutions Inc.
- Astellas Pharma Inc.
- Panacea Biotec